Pitfalls in imaging Hodgkin’s disease with computed tomography and positron emission tomography using fluorine-18-fluorodeoxyglucose

This publication has 16 references indexed in Scilit:

• 18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas
  Annals of Oncology, 2000
• Relevance of Positron Emission Tomography (PET) in Oncology
  Strahlentherapie und Onkologie, 1999
• Whole-Body Positron Emission Tomography Using18F-Fluorodeoxyglucose for Posttreatment Evaluation in Hodgkin’s Disease and Non-Hodgkin’s Lymphoma Has Higher Diagnostic and Prognostic Value Than Classical Computed Tomography Scan Imaging
  Blood, 1999
• Positron Emission Tomography (PET) for Staging and Evaluation of Response to Treatment in Patients with Hodgkin's Disease
  Leukemia & Lymphoma, 1999
• Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphoma
  Nuclear Medicine Communications, 1998
• Whole-body 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin’s disease
  Annals of Oncology, 1998
• Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography
  European Journal of Nuclear Medicine and Molecular Imaging, 1998
• CT of lymphoma: spectrum of disease.
  RadioGraphics, 1991
• Computed Tomography in the Diagnosis and Treatment of Solitary Splenic Abscesses
  Journal of Computer Assisted Tomography, 1989
• Hemangioma of the spleen: radiologic-pathologic correlation in ten cases.
  Radiology, 1987